Literature DB >> 23512209

PEGylation-aided refolding of globular adiponectin.

Mingming Gao1, Yue Tong, Xiangdong Gao, Wenbing Yao.   

Abstract

Globular adiponectin (GAD) as the active domain of adiponectin is a promising candidate for anti-diabetic drug development. The recombinant production of GAD in Escherichia coli, however, is difficult because it is mainly expressed as inclusion bodies which need to be refolded to regain function. In this study we developed a novel method for refolding of GAD with a high efficiency by using polyethylene glycol (PEG) conjugation. An artificially designed DNA sequence encoding for GAD was synthesized and inserted into the pET28a vector to construct an expression plasmid which was thereafter transformed into E. coli BL21 (DE3) host cells for heterologous expression. After bacterial cell culture employing auto-induction medium, the inclusion bodies were collected, washed and dissolved in guanidine hydrochloride before PEG conjugation. Then the PEG-conjugated GAD was refolded by dialysis and purified by two steps of chromatography. The refolded conjugate showed a marked glucose-lowering activity in mice, demonstrating that it had been successfully refolded. As a convenient method, PEGylation-aided refolding could also be tested on other proteins to explore its suitability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512209     DOI: 10.1007/s11274-013-1312-6

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  25 in total

Review 1.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

Review 2.  Purification of pegylated proteins.

Authors:  Conan J Fee; James M Van Alstine
Journal:  Methods Biochem Anal       Date:  2011

3.  Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.

Authors:  Izumi Kumagai; Ryutaro Asano; Takeshi Nakanishi; Kentaro Hashikami; Sho Tanaka; Adel Badran; Hideaki Sanada; Mitsuo Umetsu
Journal:  J Biosci Bioeng       Date:  2009-11-04       Impact factor: 2.894

4.  A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo.

Authors:  Mingming Gao; Yuhao Jin; Yue Tong; Hong Tian; Xiangdong Gao; Wenbing Yao
Journal:  J Pharm Pharmacol       Date:  2012-06-04       Impact factor: 3.765

Review 5.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

6.  Expression of a synthetic gene encoding human transthyretin in Escherichia coli.

Authors:  Kimiaki Matsubara; Mineyuki Mizuguchi; Keiichi Kawano
Journal:  Protein Expr Purif       Date:  2003-07       Impact factor: 1.650

7.  In vitro refolding of PEGylated lipase.

Authors:  Min Young Kim; Jin Sook Kwon; Hyung Jin Kim; E K Lee
Journal:  J Biotechnol       Date:  2007-08-31       Impact factor: 3.307

8.  Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.

Authors:  Masayoshi Fukushima; Yoshiyuki Hattori; Hideo Tsukada; Kimiko Koga; Eiichi Kajiwara; Kumi Kawano; Tsuneo Kobayashi; Katsuo Kamata; Yoshie Maitani
Journal:  J Gene Med       Date:  2007-11       Impact factor: 4.565

9.  Synergistic coordination of polyethylene glycol with ClpB/DnaKJE bichaperone for refolding of heat-denatured malate dehydrogenase.

Authors:  Rui Nian; Duck Sang Kim; Lihan Tan; Chan-Wha Kim; Woo-Seok Choe
Journal:  Biotechnol Prog       Date:  2009 Jul-Aug

10.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.